PFE QuantSignals V3 Earnings 2025-11-03PFE QuantSignals V3 Earnings 2025-11-03
PFE Earnings Signal | 2025-11-03
• Direction: BUY CALLS | Confidence: 72%
• Entry Plan: Open | Expiry 2025-11-07
• Strike Focus: $24.50
• Entry Range: $0.47
• Target 1: $0.94
• Stop Loss: $0.28
• Implied Move: $1.12 (4.6%)
• 24h Move: +0.06%
• Flow Intel: Bull
Key facts today
Pfizer and Novo Nordisk are currently competing for control of Metsera, a biotech firm specializing in weight-loss drug development, amid significant scrutiny from American antitrust authorities.
14,170.83
0.00 BRL
43.24 B BRL
343.01 B BRL
About Pfizer, Inc.
Sector
Industry
CEO
Albert Bourla
Website
Headquarters
New York
Founded
1849
ISIN
BRPFIZBDR006
FIGI
BBG0017227L4
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
Related stocks
Pfizer stock exploded as expected from weekly demandPfizer just did it again!
After weeks of sleeping inside that weekly demand imbalance, the pharmaceutical giant exploded — exactly as expected from our supply and demand forecast. Price has already rallied more than 7%, proving once again how powerful these imbalances can be when you learn to read
Dividend Dose & Breakout BouncePfizer has developed an interesting technical setup: the stock is currently holding above a gap around $23.50, and a breakout above $26.50 could pave the way toward the $27.69 resistance level. With a stop‑loss placed at $23.58, this trade presents a strong risk‑to‑reward ratio.
From a fundamental
Pfizer “shows its claws”: between litigation&boost searchPfizer “shows its claws”: between litigation and the search for a new boost
By Ion Jauregui – Analyst at ActivTrades
Pfizer (NYSE: PFE) is back in Wall Street’s spotlight after filing a lawsuit against Metsera (NASDAQ: MTSR) and Novo Nordisk (CPH: NOVOb), accusing them of breaching a merger agr
Pfizer’s $PFE Demand Zone — Ready to Explode?Hey traders, it’s Alfonso Moreno from Set and Forget! Today, I’m diving into one of the most famous pharmaceutical giants on the planet — Pfizer. Yes, that Pfizer. Love them or hate them, the chart doesn’t lie. The weekly timeframe just gave us a brand-new demand imbalance, and it’s looking ready to
Back test before continuationNYSE:PFE after breaking out on trump deal and now working with him to sell their products through TrumpRx launching next year. They are also exempt from tariffs for 3 years and plan to invest 60B in the US. good support/resistance flip could take place here would like to hold 25 but 24 is possible.
Pfizer (PFE): Undervalued Pharma Giant Amid #Economy Resilience?Pfizer (PFE): Undervalued Pharma Giant Amid #Economy Resilience? $28.90 in Sight? 📈
At $24.04 (+0.04%), PFE offers a compelling entry with its low P/E of 12.72 and robust 7.15% dividend yield, trading well below analyst targets of $28.90 (20% upside potential)—could resilient economic forecasts boo
Pfizer and Pharma Stocks Rise After Trump DecisionPfizer Inc. (PFE) and Other Pharmaceutical Stocks Rise Following Trump’s Decision
According to media reports, US President Donald Trump launched a website allowing Americans to purchase medicines directly. He announced that Pfizer would offer some of its drugs on this platform and introduce new me
Pfizer medium term outlook.This giant might not make you rich, but its in my opinion a safe bet for 2025>2026.
I have personally opened a long position due to my analysis.
Check my old bitcoin predictions from 4 years ago and you will see my eye is strong for longer term moves.
Make your own analysis and decision, this is
PFE: Bears Trapped at Multi-Year Lows - Spring Ready to Uncoil📍 **To see my confluences and/or linework:**
Step 1: Grab chart 📊
Step 2: Unhide Group 1 in object tree 🎯
Step 3: Hide and unhide specific confluences one by one ✨
Step 4: Double-click the screen to show RSI, MFI, CVD, and OBV indicators alongside divergence markings 📈
Title: 💊 PFE: Bears Trapp
See all ideas
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
P
PFE5588844
Pfizer Investment Enterprises Pte. Ltd. 5.34% 19-MAY-2063Yield to maturity
5.79%
Maturity date
May 19, 2063
P
PFE5588843
Pfizer Investment Enterprises Pte. Ltd. 5.3% 19-MAY-2053Yield to maturity
5.67%
Maturity date
May 19, 2053
P
PFE5588591
Pfizer Investment Enterprises Pte. Ltd. 5.11% 19-MAY-2043Yield to maturity
5.48%
Maturity date
May 19, 2043
See all PFIZ34 bonds
Curated watchlists where PFIZ34 is featured.
















